Transforming chronic wound care with breakthrough enzymatic technology
SolasCure has raised $518K in total funding. The most recent round was Grant. The last funding was announced in March 2024.
SolasCure's investors include Development Bank of Wales, European Innovation Council, Innovate UK, EIC Accelerator, Seneca Partners.
SolasCure is headquartered in Cambridge, United Kingdom.
Transforming chronic wound care with breakthrough enzymatic technology
SolasCure is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"SolasCure — Funding & Investors." VCBacked, March 20, 2024, https://www.vcbacked.co/company/solascure. Accessed July 20, 2026.
VCBacked. (2024). SolasCure — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/solascure
{{cite web |title=SolasCure — Funding & Investors |url=https://www.vcbacked.co/company/solascure |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated